AstraZeneca commits $50B to US expansion amid Trump tariff pressure

  • AstraZeneca on Monday announced plans to invest $50 billion in its US operations by 2030, a sweeping commitment that includes building its largest-ever manufacturing facility in Virginia and expanding research and development across several states.